The recent bankruptcy announcement of 23andMe, a leading direct-to-consumer genetic testing company, has spurred significant discussions about the security and privacy of genetic data. As the company navigates financial turmoil and operational challenges, concerns mount over the future of the
The notion of genetically engineering an unborn child's sexual orientation has stirred debates among ethicists, scientists, and religious groups. This discourse stems from the suggestion that, with advancements in scientific knowledge, it might be possible to determine an unborn child's
Sepsis, a critical and often fatal condition resulting from the body's response to an infection, continues to pose significant challenges in both diagnosis and treatment. Researchers are increasingly focused on understanding the pivotal role of autophagy-related genes in sepsis, aiming to
Human evolution has always captured our imagination, leading to discoveries that continuously reshape our understanding of our origins. Researchers at the University of Cambridge have made a significant breakthrough, revealing that all modern humans share DNA from two ancient populations. These
Ivan Kairatov is a Biopharma expert with extensive knowledge in technology and innovation within the industry and considerable experience in research and development. Today, we discuss the newly introduced Genomic Data Protection Act (GDPA) and its implications. Can you explain the main purpose of
Alpha-1 antitrypsin deficiency (AATD) is a genetic disorder that significantly impacts both liver and lung function, resulting in a rare but severe health burden. In an ambitious and promising development, Prime Medicine is leveraging its innovative gene editing technology to address this
